News

Laekna Therapeutics, a clinical-stage global biotechnology company dedicated to developing next generation medicines to treat cancer and liver diseases, announced that it has raised $61…
Read More...

Tonix Pharmaceuticals Holding Corp. announced it has entered into a license agreement and extended a research collaboration with the University of Alberta, a leading Canadian research…
Read More...

PostEra, a biotechnology company specializing in machine learning for preclinical drug discovery, announced a multi-year collaboration with the National Institutes of Health to develop…
Read More...

SwanBio Therapeutics, a gene therapy company advancing adeno-associated virus (AAV)-based therapies for the treatment of devastating, inherited neurological conditions, today announced…
Read More...

AstraZeneca has entered into a licence agreement with RQ Biotechnology Ltd (RQ Bio) for a portfolio of early-stage monoclonal antibodies (mAbs) targeted against SARS-CoV-2, the virus…
Read More...

Pfizer Inc. and BioNTech SE announced the U.S. Food and Drug Administration (FDA) expanded emergency use authorization (EUA) to include a booster dose after completion of the primary…
Read More...

Sernova Corp. a clinical-stage company and leader in regenerative medicine cell therapeutics, and Evotec SE a global pharmaceutical and life science company, and leading developer of…
Read More...

Zealand Pharma A/S a biotechnology company focused on the discovery and development of innovative peptide-based medicines, announced it has entered into an asset purchase agreement with…
Read More...

Proscia, a leader in digital and computational pathology solutions, has introduced an automated quality control application that leverages artificial intelligence to improve quality and…
Read More...

SIMCERE PHARMA announced that SIM0417, a candidate drug against SARS-Cov-2, for which the Company holds license from Shanghai Institute of Materia Medica (SIMM) and Wuhan Institute of…
Read More...

PerkinElmer, Inc., a global leader committed to innovating for a healthier world, announced the availability of ultrarapid whole genome sequencing (urWGS) through PerkinElmer Genomics.…
Read More...

Proteros biostructures GmbH (“Proteros”), an expert in integrated structure-based drug discovery, announces an expansion of its collaboration with AstraZeneca focused on the discovery…
Read More...

Kriya Therapeutics, Inc., a fully integrated gene therapy company pioneering novel technologies and therapeutics, announced a $270 Million Series C financing. The financing was led by…
Read More...

AbbVie and Cugene Inc., a clinical-stage biotechnology company focused on developing next-generation precision immunology and oncology medicines to treat autoimmune disease and cancer,…
Read More...

Pfizer Inc. and BioNTech SE announced they have reached an agreement with the European Commission (EC) to amend their originally agreed contractual delivery schedules for the…
Read More...

Valneva SE, a specialty vaccine company, announced that it has received a notice from the European Commission (“EC”) of intent to terminate the advance purchase agreement (“APA”) for…
Read More...

Statera Biopharma a biopharmaceutical company creating next-generation immune therapies that focus on immune restoration and homeostasis, announced today that the Company intends to…
Read More...

Inmagene Biopharmaceuticals announces that the U.S. Food and Drug Administration (FDA) cleared its investigational new drug (IND) application for the drug candidate IMG-004, a…
Read More...

Editas Medicine, Inc. a leading genome editing company, announced that the U.S. Food and Drug Administration (FDA) granted Orphan Drug Designation to EDIT-301, an investigational, gene…
Read More...

The U.S. Food and Drug Administration (FDA) approved Mounjaro (tirzepatide) injection, Eli Lilly and Company's (NYSE: LLY) new once-weekly GIP (glucose-dependent insulinotropic…
Read More...